SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
______________________
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
Pursuant to Rule 13a-16 or 15d-16 of the
Securities Exchange Act of 1934
For the month of February 2016
Commission File Number: 001-36073
Enzymotec Ltd.
(Translation of registrant’s name into English)
Sagi 2000 Industrial Area
P.O. Box 6
Migdal Ha’Emeq 2310001, Israel
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F x Form 40-F o
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): __
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): __
EXPLANATORY NOTE
On February 17, 2016, Enzymotec Ltd. issued a press release entitled “Enzymotec Ltd. Reports Fourth Quarter and Full Year 2015 Results”. A copy of this press release is attached to this Form 6-K as Exhibit 99.1.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| | ENZYMOTEC LTD. | |
| Date: February 17, 2016 | By: | /s/ Oren Bryan | |
| | Name: | Oren Bryan | |
| | Title: | Chief Financial Officer | |
EXHIBIT INDEX
The following exhibit is filed as part of this Form 6-K:
| Exhibit | Description |
| 99.1 | Press release dated February 17, 2016 entitled “Enzymotec Ltd. Reports Fourth Quarter and Full Year 2015 Results”. |
4
